EX-99.1 2 ea159378ex99-1_ontrack.htm POSITION NOTICE OF SHAREHOLDERS DATED APRIL 28, 2022.

Exhibit 99.1

 

April 28th, 2022

 

TO:

 

On Track Innovations Ltd.

 

5 Hatnufa St., Yokneam Industrial Zone

 

Yokneam, Israel, 2069200

 

Re: Shareholders Position Notice - extraordinary general meeting of On Track Innovations Ltd. (“OTI”)

 

The Position Notice below is being submitted on behalf of the following shareholders of OTI in connection with the Items included on the agenda of the extraordinary general meeting of OTI scheduled for May 10, 2022.

 

Name   Number of shares (thousands)
Sandy Leff   3,215  
Amjad Khan   250  
Massimo Giunta   110  
Mark Brody   207  
Jeffrey Altman   450  
Shem-Tov Cohen   14  
Norbert Hell   460  
Ariel Lifshitz   1,320  
Marshall Rapaport   207  
Holger Mueller   1,075  
Dr. Ralf Hammer   1,930  
Anton Cindric   350  
Andreas Siegl   372  
Thomas Pott   100  
Klaus Erfkämper   200  
Andre Barabas   60  
Michael Oldenkott   170  
H. Strüber   920  
S. Strüber   120  
Ulli Göttler   400  
Recep Aydin   40  
Werner Didam   355  
Klaus Böer   140  
Norbert Wellmann   70  
Hartmut Franke   1,351  
Eric Herbst   30  
Robert Goldenbaum   87  
Dirk Lesmann   10  
Stephan Schlett   60  
Ove Martensen   130  
Frederick Sondermann   40  
Dario Barbarino   55  
Luigina Barbarino   25  
Sakellaris Vlamos   621  
Peter Seegler   50  
Jens Lüpke   60  
Holger Lange   100  
Lasse Wittke   34  
Bernhard Zehetgruber   40  

 

2

 

 

POSITION NOTICE

 

This Notice presents position of 39 shareholders, with aggregate holding of 20.5% of OTI shares.

 

We urge other shareholders to consider this position and vote as advised below. We urge shareholders to join us at [email protected]

 

We do not oppose Nayax Ltd.’s expression of interest in OTI and welcome a suitable partnership between the two companies. However, we strongly oppose the current $4.5 million consideration proposed. Our position, as significant and well-informed shareholders, is that the fair value of OTI is much higher.

 

We see it as an attempt to “squeeze out” minority shareholders, with questionable legality.

 

Reasons for our position:

 

1. The consideration of 5.94 cents per share, minus Israeli tax withholding, is not justifiable by any reasonable valuation method, nor does the Proxy pretend so. The Proxy does not explain how this Compensation was determined or negotiated. No fair value determination and no negotiations were done. Company did not make available any appraisal and the shareholders were not presented any “fairness opinion”, or at minimum, a self-appraisal by OTI. Latest funding event, oversubscribed, just nine months ago, was at 17.2 cents per share. Current proposal reflects valuation drop of two-thirds, seeming not to reflect Company’s fair value.

 

2. Proxy describes negotiation process to have consisted of just one(!) telephone conversation late evening, clearly not a proper and reasonable process for such transaction. We expect OTI’s management to negotiate such fundamental transaction in more careful and adequate manner.

 

3. For the right investor/partner, the high amount tax losses carry-forwards represent significant value which is expected to be reflected in Company’s valuation.

 

4. We urge the Company and the Company’s controlling shareholder to disclose any potential connections between them and Nayax and any affiliates thereof (including potential other transactions between them).

 

5. We understand OTI’s cash-flow needs; that can be addressed in various ways that do not terminally compromise shareholders’ interests, e.g. sale of asset(s), a new Offering, new strategic investor, PIPE, etc.

 

In summary, this deal was rashly structured, is not based on any objective standard valuation criteria, was not adequately negotiated, the proposed consideration does not reflect the Company’s fair value – therefore proposed transaction does not serve the Company’s and the Company’s shareholders best interests!

 

In addition, note Question 1b. is phrased in potentially misleading manner, as “double negative”. You may be inclined to vote Against (No) and disqualify. Read carefully.

 

25% opposition is sufficient to reject proposed deal! Vote against and join our 20.5%.

 

We intend to vote:

 

question 1a. Against

 

question 1b. Yes (read carefully!)

 

question 2. Against

 

question 3. Against

 

We urge other investors to consider this position and vote as advised above. We urge shareholders to join us at [email protected]

 

In addition, we note that shareholders holding OTIVF shares in non-USA bank/brokerage accounts have not received their control-numbered Proxy Cards from bank/brokerage and cannot vote. Therefore, we urge the Company to provide all shareholders with a Personal Proxy Card, as customary, and to delay the voting deadline accordingly.

 

 

3